These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 12136837)

  • 1. Meta-analysis of measures of sexual activity and prostate cancer.
    Seftel A
    J Urol; 2002 Aug; 168(2):863. PubMed ID: 12136837
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate cancer and sexually transmitted diseases: a meta-analysis.
    Taylor ML; Mainous AG; Wells BJ
    Fam Med; 2005; 37(7):506-12. PubMed ID: 15988645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should function and bother be measured and reported separately for prostate cancer quality-of-life domains?
    Reeve BB; Potosky AL; Willis GB
    Urology; 2006 Sep; 68(3):599-603. PubMed ID: 16979720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study.
    Stephenson RA; Mori M; Hsieh YC; Beer TM; Stanford JL; Gilliland FD; Hoffman RM; Potosky AL
    J Urol; 2005 Aug; 174(2):646-50; discussion 650. PubMed ID: 16006930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' perceptions of quality of life after treatment for early prostate cancer.
    Clark JA; Inui TS; Silliman RA; Bokhour BG; Krasnow SH; Robinson RA; Spaulding M; Talcott JA
    J Clin Oncol; 2003 Oct; 21(20):3777-84. PubMed ID: 14551296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual, psychological and dyadic qualities of the prostate cancer 'couple'.
    Soloway CT; Soloway MS; Kim SS; Kava BR
    BJU Int; 2005 Apr; 95(6):780-5. PubMed ID: 15794782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
    McNaughton-Collins M; Walker-Corkery E; Barry MJ
    J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis linking UCLA PCI with Expanded Prostate Cancer Index Composite: an evaluation of health related quality of life in Japanese men with localized prostate cancer.
    Namiki S; Takegami M; Kakehi Y; Suzukamo Y; Fukuhara S; Arai Y
    J Urol; 2007 Aug; 178(2):473-7; discussion 477. PubMed ID: 17561164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer and consistency of reporting sexual histories in men over age 50.
    Dennis LK; Ritchie JM; Resnick MI
    Prostate Cancer Prostatic Dis; 2005; 8(3):243-7. PubMed ID: 15983628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual intimacy in heterosexual couples after prostate cancer treatment: What we know and what we still need to learn.
    Beck AM; Robinson JW; Carlson LE
    Urol Oncol; 2009; 27(2):137-43. PubMed ID: 18367118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The psychosocial aspects of sexual recovery after prostate cancer treatment.
    Wittmann D; Northouse L; Foley S; Gilbert S; Wood DP; Balon R; Montie JE
    Int J Impot Res; 2009; 21(2):99-106. PubMed ID: 19158798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical interpretation of the Expanded Prostate Cancer Index Composite-Short Form sexual summary score.
    Wheat JC; Hedgepeth RC; He C; Zhang L; Wood DP
    J Urol; 2009 Dec; 182(6):2844-9. PubMed ID: 19837418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of treatment choice for localized prostate cancer on response to phosphodiesterase inhibitors.
    Lee IH; Sadetsky N; Carroll PR; Sandler HM
    J Urol; 2008 Mar; 179(3):1072-6; discussion 1076. PubMed ID: 18206926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical activity and sexual functioning after radiotherapy for prostate cancer: beneficial effects for patients undergoing external beam radiotherapy.
    Dahn JR; Penedo FJ; Molton I; Lopez L; Schneiderman N; Antoni MH
    Urology; 2005 May; 65(5):953-8. PubMed ID: 15882730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men.
    Sarma AV; McLaughlin JC; Wallner LP; Dunn RL; Cooney KA; Schottenfeld D; Montie JE; Wei JT
    J Urol; 2006 Sep; 176(3):1108-13. PubMed ID: 16890703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of diabetes mellitus and the risk of prostate cancer.
    Kasper JS; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2056-62. PubMed ID: 17119028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary use of hormonal therapy in prostate cancer: managing complications and addressing quality-of-life issues.
    Gomella LG
    BJU Int; 2007 Jan; 99 Suppl 1():25-9; discussion 30. PubMed ID: 17229166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant hormonal therapy impairs sexual outcome among younger men who undergo external beam radiotherapy for localized prostate cancer.
    Hollenbeck BK; Wei JT; Sanda MG; Dunn RL; Sandler HM
    Urology; 2004 May; 63(5):946-50. PubMed ID: 15134986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of quality of life after radical treatment for prostate cancer.
    Gacci M; Lapini A; Serni S; Livi L; Paiar F; Detti B; Simontacchi G; Vittori G; Giubilei G; Mariani M; Palli D; Carini M
    Urol Int; 2008; 80(3):231-6. PubMed ID: 18480622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis.
    Shaik AP; Jamil K; Das P
    Urol J; 2009; 6(2):78-86. PubMed ID: 19472123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.